DCLK3 and central nervous system cancer: Parallel pathways operate through the CGRP/adrenomedullin family: glioma specimens up-regulate adrenomedullin-2, whose ligation of CLR–RAMP2 boosts ERK1/2 activation, enhances filopodia formation and potentiates temozolomide resistance (49).